Hikma Pharmaceuticals Plc Director/PDMR Shareholding (1186C)
08 6월 2023 - 6:25PM
UK Regulatory
TIDMHIK
RNS Number : 1186C
Hikma Pharmaceuticals Plc
08 June 2023
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Douglas Hurt
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Market purchase of 1500 Ordinary Shares by Gillian
transaction Hurt, spouse of Douglas Hurt
c) Price(s) and Price(s): GBP18.20
volume(s) Volume(s):1500
d) Aggregated information
* Volume
1500
GBP18.20
* Price GBP27,300
* Total
e) Date of the transaction 6 June 2023
f) Place of the London Stock Exchange (XLON)
transaction
Helen Middlemist, Deputy Company Secretary
+44 (0) 20 7399 2760
8 June 2023
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHGCGDLXDGDGXI
(END) Dow Jones Newswires
June 08, 2023 05:25 ET (09:25 GMT)
Hikma Pharmaceuticals (LSE:HIK)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Hikma Pharmaceuticals (LSE:HIK)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024